Clinical Chemistry Analyzers Market
Clinical Chemistry Analyzers Market Forecasts to 2030 - Global Analysis By Product (Benchtop Analyzers, Floor-standing Analyzers, Portable Analyzers, Modular Analyzers, Integrated Analyzers and Other Products), Test Type, Modality, Technology, Application, End User and By Geography
According to Stratistics MRC, the Global Clinical Chemistry Analyzers Market is accounted for $14.17 billion in 2023 and is expected to reach $17.26 billion by 2030 growing at a CAGR of 6.2% during the forecast period. Clinical Chemistry Analyzers are sophisticated medical instruments designed to analyze various chemical components in blood, urine, and other bodily fluids. These automated systems play a crucial role in diagnosing and monitoring diseases by measuring concentrations of substances like glucose, cholesterol, and enzymes. Their precision and automation enhance the reliability and speed of laboratory diagnostics in clinical settings.
According to the Canadian Cancer Society's 2021 report, about 229,200 new cancer cases will be diagnosed in Canada in 2021, and on average, 628 Canadians are diagnosed with cancer every day. The rising number of chronic diseases in the nation adds to the growth of clinical chemistry analyzers in the North American region.
Market Dynamics:
Driver:
Increasing prevalence of chronic diseases
The need for accurate and timely clinical chemistry analysis intensifies, as chronic conditions such as diabetes, cardiovascular diseases, and kidney disorders become more prevalent. Clinical chemistry analyzers play a crucial role in monitoring and managing these conditions, fostering their widespread adoption in healthcare settings. This trend is likely to persist, contributing to the market's sustained growth as the healthcare industry strives to address the challenges posed by the rising burden of chronic diseases.
Restraint:
Lack of skilled personnel
The complex nature of clinical chemistry analysis requires trained professionals for accurate operation and interpretation of results. The complexity of these instruments demands a workforce with a deep understanding of analytical techniques, laboratory protocols, and data interpretation. Addressing this skill gap becomes crucial for unlocking the full potential of clinical chemistry analyzers, potentially hindering their widespread adoption and optimal functionality in healthcare settings.
Opportunity:
Shift towards personalized medicine
Personalized medicine tailors healthcare interventions to individual characteristics, optimizing treatment efficacy. Clinical chemistry analyzers play a crucial role by providing detailed patient profiles, enabling precise diagnostics and treatment monitoring. As the demand for personalized healthcare rises, the market for advanced and adaptable analyzers is poised for expansion, creating a promising avenue for innovation and growth in the clinical chemistry sector.
Threat:
High operational costs & maintenance expenses
Clinical Chemistry Analyzers incur high operational costs and maintenance expenses due to their intricate design, sophisticated technology, and stringent regulatory requirements. These analyzers demand precision and reliability, necessitating complex components and rigorous quality control. Regular calibration, maintenance, and compliance with evolving standards contribute to ongoing expenses. These financial challenges collectively hamper the market expansion.
Covid-19 Impact
The covid-19 pandemic has significantly impacted the Clinical Chemistry Analyzers market. The increased demand for diagnostic testing, including biochemical analysis, drove market growth. However, disruptions in the supply chain, reduced healthcare facility budgets, and workforce shortages posed challenges. The emphasis on rapid and accurate testing solutions, coupled with ongoing advancements in technology, stimulated innovation in the clinical chemistry analyzers sector. The market exhibited resilience, adapting to the evolving healthcare landscape and prioritizing solutions to address the diagnostic needs arising from the pandemic.
The portable analyzers segment is expected to be the largest during the forecast period
The portable analyzers segment is estimated to have a lucrative growth, due to their rapid and accurate results. Portable clinical chemistry analyzers are compact diagnostic devices that enable on-the-go testing of blood samples for various medical parameters. They are designed to measure a range of analytes, including glucose, cholesterol, and electrolytes, facilitating quick diagnosis and monitoring of various medical conditions. Their portability enhances accessibility to diagnostic capabilities, particularly in resource-limited or remote areas.
The therapeutic drug monitoring (TDM) segment is expected to have the highest CAGR during the forecast period
The therapeutic drug monitoring (TDM) segment is anticipated to witness the highest CAGR growth during the forecast period. Therapeutic Drug Monitoring (TDM) is crucial in Clinical Chemistry Analyzers to ensure optimal medication levels for patients. These analyzers measure drug concentrations in biological samples, enabling healthcare professionals to adjust dosage regimens based on individual patient responses. TDM enhances treatment efficacy, minimizes side effects, and addresses variability in drug metabolism which accelerates the segment growth.
Region with largest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing healthcare infrastructure, rising prevalence of chronic diseases, and a growing emphasis on early disease detection. It also has the presence of major companies namely Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories and Roche Diagnostics. The supportive government initiatives and high implementation of practice guidelines released by healthcare organizations are present across this region. Furthermore, high R&D investment by the global players and presence of unexplored opportunities in this region serve as high growth rendering drivers.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, driven by advancements in healthcare technology and the increasing prevalence of chronic diseases. The region's well-established healthcare infrastructure, coupled with a rising aging population, has led to a higher demand for diagnostic services, boosting the market for clinical chemistry analyzers. Key players in the industry are focusing on product innovation and strategic collaborations to maintain a competitive edge. Further, the adoption of automated systems and point-of-care testing solutions is contributing to market expansion.
Key players in the market
Some of the key players profiled in the Clinical Chemistry Analyzers Market include Abbott Laboratories, Mindray Medical International Limited, Siemens AG, F. Hoffmann-La Roche Limited, Danaher Corporation, Sysmex Corporation, Thermo Fisher Scientific Inc., HITACHI, Horiba Medical Limited, EKF Diagnostics, Roche Diagnostics, Ortho Clinical Diagnostics, Bio-Rad Laboratories, Randox Laboratories, ELITechGroup, DiaSorin, Shimadzu Corporation and EDAN Instruments.
Key Developments:
In May 2023, Siemens Healthineers launched the Atellica HEMA 570 and 580 Analyzers. These analyzers are designed for high-volume hematology testing. They are intended to streamline testing by integrating automation. The analyzers also have intuitive interfaces and multi-analyzer automation connectivity.
In July 2022, EDAN Instruments launched its POC fluorescence-based CO-OX blood gas and chemistry analysis system, i20, with the capacity to analyze over 45 parameters, covering everything from blood gases to electrolytes to CO-oximetry.
In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability.
Products Covered:
• Benchtop Analyzers
• Floor-standing Analyzers
• Portable Analyzers
• Modular Analyzers
• Integrated Analyzers
• Other Products
Test Types Covered:
• Basic Metabolic Panels
• Liver Panels
• Electrolyte Panels
• Lipid Profiles
• Thyroid Function Panels
• Renal Function Panels
• Specialty Panels
Modalities Covered:
• Fully Automated Analyzers
• Semi-Automated Analyzers
• Point-of-Care (POC) Analyzers
Technologies Covered:
• Enzymatic Assay Technology
• Ion-Selective Electrode (ISE) Technology
• Colorimetric Technology
• Chemiluminescence Immunoassay (CLIA) Technology
• Fluorescence Technology
• Electrochemical Biosensors
• Molecular Diagnostics Technology
Applications Covered:
• Routine Chemistry Testing
• Special Chemistry Testing
• Therapeutic Drug Monitoring (TDM)
• Endocrinology Applications
• Cardiac Markers Testing
• Infectious Disease Testing
• Other Applications
End Users Covered:
• Hospitals
• Diagnostic Laboratories
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Academic Research Centers
• Point-of-Care Testing (POCT) Facilities
• Home Healthcare Settings
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Chemistry Analyzers Market, By Product
5.1 Introduction
5.2 Benchtop Analyzers
5.3 Floor-standing Analyzers
5.4 Portable Analyzers
5.5 Modular Analyzers
5.6 Integrated Analyzers
5.7 Other Products
6 Global Clinical Chemistry Analyzers Market, By Test Type
6.1 Introduction
6.2 Basic Metabolic Panels
6.3 Liver Panels
6.4 Electrolyte Panels
6.5 Lipid Profiles
6.6 Thyroid Function Panels
6.7 Renal Function Panels
6.8 Specialty Panels
7 Global Clinical Chemistry Analyzers Market, By Modality
7.1 Introduction
7.2 Fully Automated Analyzers
7.3 Semi-Automated Analyzers
7.4 Point-of-Care (POC) Analyzers
8 Global Clinical Chemistry Analyzers Market, By Technology
8.1 Introduction
8.2 Enzymatic Assay Technology
8.3 Ion-Selective Electrode (ISE) Technology
8.4 Colorimetric Technology
8.5 Chemiluminescence Immunoassay (CLIA) Technology
8.6 Fluorescence Technology
8.7 Electrochemical Biosensors
8.8 Molecular Diagnostics Technology
9 Global Clinical Chemistry Analyzers Market, By Application
9.1 Introduction
9.2 Routine Chemistry Testing
9.3 Special Chemistry Testing
9.4 Therapeutic Drug Monitoring (TDM)
9.5 Endocrinology Applications
9.6 Cardiac Markers Testing
9.7 Infectious Disease Testing
9.8 Other Applications
10 Global Clinical Chemistry Analyzers Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Research Institutes
10.5 Pharmaceutical & Biotechnology Companies
10.6 Academic Research Centers
10.7 Point-of-Care Testing (POCT) Facilities
10.8 Home Healthcare Settings
11 Global Clinical Chemistry Analyzers Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Abbott Laboratories
13.2 Mindray Medical International Limited
13.3 Siemens AG
13.4 F. Hoffmann-La Roche Limited
13.5 Danaher Corporation
13.6 Sysmex Corporation
13.7 Thermo Fisher Scientific Inc.
13.8 HITACHI
13.9 Horiba Medical Limited
13.10 EKF Diagnostics
13.11 Roche Diagnostics
13.12 Ortho Clinical Diagnostics
13.13 Bio-Rad Laboratories
13.14 Randox Laboratories
13.15 ELITechGroup
13.16 DiaSorin
13.17 Shimadzu Corporation
13.18 EDAN Instruments
List of Tables
1 Global Clinical Chemistry Analyzers Market Outlook, By Region (2021-2030) ($MN)
2 Global Clinical Chemistry Analyzers Market Outlook, By Product (2021-2030) ($MN)
3 Global Clinical Chemistry Analyzers Market Outlook, By Benchtop Analyzers (2021-2030) ($MN)
4 Global Clinical Chemistry Analyzers Market Outlook, By Floor-standing Analyzers (2021-2030) ($MN)
5 Global Clinical Chemistry Analyzers Market Outlook, By Portable Analyzers (2021-2030) ($MN)
6 Global Clinical Chemistry Analyzers Market Outlook, By Modular Analyzers (2021-2030) ($MN)
7 Global Clinical Chemistry Analyzers Market Outlook, By Integrated Analyzers (2021-2030) ($MN)
8 Global Clinical Chemistry Analyzers Market Outlook, By Other Products (2021-2030) ($MN)
9 Global Clinical Chemistry Analyzers Market Outlook, By Test Type (2021-2030) ($MN)
10 Global Clinical Chemistry Analyzers Market Outlook, By Basic Metabolic Panels (2021-2030) ($MN)
11 Global Clinical Chemistry Analyzers Market Outlook, By Liver Panels (2021-2030) ($MN)
12 Global Clinical Chemistry Analyzers Market Outlook, By Electrolyte Panels (2021-2030) ($MN)
13 Global Clinical Chemistry Analyzers Market Outlook, By Lipid Profiles (2021-2030) ($MN)
14 Global Clinical Chemistry Analyzers Market Outlook, By Thyroid Function Panels (2021-2030) ($MN)
15 Global Clinical Chemistry Analyzers Market Outlook, By Renal Function Panels (2021-2030) ($MN)
16 Global Clinical Chemistry Analyzers Market Outlook, By Specialty Panels (2021-2030) ($MN)
17 Global Clinical Chemistry Analyzers Market Outlook, By Modality (2021-2030) ($MN)
18 Global Clinical Chemistry Analyzers Market Outlook, By Fully Automated Analyzers (2021-2030) ($MN)
19 Global Clinical Chemistry Analyzers Market Outlook, By Semi-Automated Analyzers (2021-2030) ($MN)
20 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care (POC) Analyzers (2021-2030) ($MN)
21 Global Clinical Chemistry Analyzers Market Outlook, By Technology (2021-2030) ($MN)
22 Global Clinical Chemistry Analyzers Market Outlook, By Enzymatic Assay Technology (2021-2030) ($MN)
23 Global Clinical Chemistry Analyzers Market Outlook, By Ion-Selective Electrode (ISE) Technology (2021-2030) ($MN)
24 Global Clinical Chemistry Analyzers Market Outlook, By Colorimetric Technology (2021-2030) ($MN)
25 Global Clinical Chemistry Analyzers Market Outlook, By Chemiluminescence Immunoassay (CLIA) Technology (2021-2030) ($MN)
26 Global Clinical Chemistry Analyzers Market Outlook, By Fluorescence Technology (2021-2030) ($MN)
27 Global Clinical Chemistry Analyzers Market Outlook, By Electrochemical Biosensors (2021-2030) ($MN)
28 Global Clinical Chemistry Analyzers Market Outlook, By Molecular Diagnostics Technology (2021-2030) ($MN)
29 Global Clinical Chemistry Analyzers Market Outlook, By Application (2021-2030) ($MN)
30 Global Clinical Chemistry Analyzers Market Outlook, By Routine Chemistry Testing (2021-2030) ($MN)
31 Global Clinical Chemistry Analyzers Market Outlook, By Special Chemistry Testing (2021-2030) ($MN)
32 Global Clinical Chemistry Analyzers Market Outlook, By Therapeutic Drug Monitoring (TDM) (2021-2030) ($MN)
33 Global Clinical Chemistry Analyzers Market Outlook, By Endocrinology Applications (2021-2030) ($MN)
34 Global Clinical Chemistry Analyzers Market Outlook, By Cardiac Markers Testing (2021-2030) ($MN)
35 Global Clinical Chemistry Analyzers Market Outlook, By Infectious Disease Testing (2021-2030) ($MN)
36 Global Clinical Chemistry Analyzers Market Outlook, By Other Applications (2021-2030) ($MN)
37 Global Clinical Chemistry Analyzers Market Outlook, By End User (2021-2030) ($MN)
38 Global Clinical Chemistry Analyzers Market Outlook, By Hospitals (2021-2030) ($MN)
39 Global Clinical Chemistry Analyzers Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
40 Global Clinical Chemistry Analyzers Market Outlook, By Research Institutes (2021-2030) ($MN)
41 Global Clinical Chemistry Analyzers Market Outlook, By Pharmaceutical & Biotechnology Companies (2021-2030) ($MN)
42 Global Clinical Chemistry Analyzers Market Outlook, By Academic Research Centers (2021-2030) ($MN)
43 Global Clinical Chemistry Analyzers Market Outlook, By Point-of-Care Testing (POCT) Facilities (2021-2030) ($MN)
44 Global Clinical Chemistry Analyzers Market Outlook, By Home Healthcare Settings (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.